Neuronetics (STIM) EBITDA Margin (2017 - 2026)
Neuronetics (STIM) reported EBITDA Margin of 26.11% for Q1 2026, up 834.0% year-over-year from 2.8% in Q1 2025, and down 116.28% quarter-over-quarter from 12.07% in Q4 2025.
Neuronetics (STIM) EBITDA Margin (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of EBITDA Margin data on file, last reported at 26.11% in Q1 2026.
- EBITDA Margin for Q1 2026 came in at 26.11%, up 834.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 19.4% (up 2389.0% YoY), and the FY2025 annual result was 21.08%, up 2508.0% from the prior year.
- EBITDA Margin retreated to 26.11% in Q1 2026 per STIM's latest filing, from 12.07% in the prior quarter.
- Over five years, EBITDA Margin peaked at 12.07% in Q4 2025 and troughed at 71.47% in Q1 2022.
- A 5-year average of 40.78% and a median of 41.73% in 2023 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin sank 2921 bps in 2024, then soared 3893 bps in 2025.
- A 5-year view of EBITDA Margin shows it stood at 42.46% in 2022, then jumped by 49 bps to 21.79% in 2023, then plunged by 134 bps to 51.0% in 2024, then jumped by 76 bps to 12.07% in 2025, then tumbled by 116 bps to 26.11% in 2026.
- Business Quant data shows STIM's EBITDA Margin at 26.11% in Q1 2026, 12.07% in Q4 2025, and 19.63% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Neuronetics | 2.40 Mn | -7.28 Mn | 16.15 Mn | -26.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.11% |
| Dec 31, 2025 | -12.07% |
| Sep 30, 2025 | -19.63% |
| Jun 30, 2025 | -21.15% |
| Mar 31, 2025 | -34.45% |
| Dec 31, 2024 | -51.00% |
| Sep 30, 2024 | -41.71% |
| Jun 30, 2024 | -51.71% |
| Mar 31, 2024 | -39.38% |
| Dec 31, 2023 | -21.79% |
| Sep 30, 2023 | -49.60% |
| Jun 30, 2023 | -41.73% |
| Mar 31, 2023 | -63.75% |
| Dec 31, 2022 | -42.46% |
| Sep 30, 2022 | -45.18% |
| Jun 30, 2022 | -59.99% |
| Mar 31, 2022 | -71.47% |
| Dec 31, 2021 | -45.99% |
| Sep 30, 2021 | -52.05% |
| Jun 30, 2021 | -46.22% |